Dyslipidemia marker | in an emergency room | after 4 days | after 1 month | after interruption of therapy | 1 month after treatment restart | 1.5 months after treatment restart | Reference range |
---|---|---|---|---|---|---|---|
Total cholesterol (mg/dL) | 1055 | 705 | 233 | 1368 | 131 | 224 | 142–248 |
LDL cholesterol (mg/dL) | 240 | 117 | 96 | 490 | 78 | 151 | 65–139 |
HDL cholesterol (mg/dL) | 17 | 20 | 34 | 11 | 26 | 31 | 40–90 |
Triglyceride (mg/dL) | 11,175 | 5555 | 675 | 16,900 | 298 | 328 | 40–149 |
RLP- cholesterol (mg/dL) | N/A | 264.8 | N/A | 414.9 | N/A | 15.8 | 0.0–7.5 |
Apolipoprotein A-I (mg/dL) | 121 | N/A | 84 | 119–155 | |||
Apolipoprotein A-II (mg/dL) | N/A | N/A | 15.1 | 25.9–35.7 | |||
Apolipoprotein B (mg/dL) | 145 | N/A | 140 | 73–109 | |||
Apolipoprotein C-II (mg/dL) | N/A | N/A | 9.1 | 1.8–4.6 | |||
Apolipoprotein C-III (mg/dL) | N/A | N/A | 11.8 | 5.8–10.0 | |||
Apolipoprotein E (mg/dL) | 33.4 | N/A | 7.0 | 2.7–4.3 | |||
lipoprotein fractions | |||||||
VLDL (%) | 44 | 52 | 16 | 3–19 | |||
MIDBAND (%) | 33 | 37 | 24 | ||||
LDL (%) | 9 | 6 | 46 | 46–68 | |||
HDL (%) | 11 | 5 | 14 | 22–74 | |||
BAND (%) | 3 | – | – | ||||
pre-heparin LPL (ng/mL) | N/A | N/A | 35 | ||||
Diabetes marker | in an emergency room | after 4 days | after 1 month | after interruption of therapy | 1 month after treatment restart | 1.5 months after treatment restart | Reference range |
Plasma Glucose (mg/dL) | 260 | N/A | 277 | 310 | 115 | 110 | 73–109 |
Glycoalbumin (%) | 33.5 | N/A | 25.0 | 27.8 | 23.2 | 21.6 | 12.4–16.3 |
Total ketone bodies (μmol/L) | N/A | 1275.1 | 88.6 | 3870.0 | 64.8 | 648.0 | 0.0–130.0 |
Acetoacetate (μmol/L) | N/A | 524.3 | 46.8 | 1610.0 | 30.9 | 216.9 | 0.0–55.0 |
Beta-hydroxybutylate (μmol/L) | N/A | 750.8 | 41.8 | 2260.0 | 33.9 | 431.1 | 0.0–85.0 |